Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Dabrafenib (mesylate) | 1195768-06-9 | 99.9% | 615.67 | 50 MG
SDP

Catalog No. 5000360913
Encompass_Preferred

Dabrafenib Mesylate is a potent and selective Raf kinase inhibitor with IC50s of 0.6 and 5.0 nM for RafV600E and c-Raf, respectively. It is intended for research use.

  • Inhibits over 90% of cell growth in NRAS mutant clones
  • Reduces S6P phosphorylation in A375 cells
  • Suppresses PolyP-mediated vascular barrier permeability
  • Downregulates HMGB1-dependent inflammatory responses
  • Enhances the expression of cell adhesion molecules (CAMs) in human endothelial cells

Catalog No. 50-003-60913 Supplier Medchemexpress LLC Supplier No. HY14660A50MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Dabrafenib Mesylate is a potent and selective Raf kinase inhibitor with IC50s of 0.6 and 5.0 nM for RafV600E and c-Raf, respectively. It is intended for research use.

  • Inhibits over 90% of cell growth in NRAS mutant clones
  • Reduces S6P phosphorylation in A375 cells
  • Suppresses PolyP-mediated vascular barrier permeability
  • Downregulates HMGB1-dependent inflammatory responses
  • Enhances the expression of cell adhesion molecules (CAMs) in human endothelial cells

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.